<?xml version="1.0" encoding="iso-8859-1"?><?xml-stylesheet href="http://www.congoo.com/css/rss.css" type="text/css" media="screen"?><rss version="2.0"><channel><title>Cancer News - Congoo</title><link>http://www.congoo.com/feed/newschannelsfeed.aspx?chid=22&amp;catid=262</link><description>News Feed for - Cancer</description><item><title>US women 'to ignore breast exam advice'</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96359536&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:08:00</pubDate><description>AFP Three-quarters of US women disagree with a high-level panel's recommendations to raise the age of breast cancer screening and even more plan to ignore the guidelines, a poll showed. Of 1,136 women </description><source>The Age</source></item><item><title>ER phosphorylation tied to improved tamoxifen response</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96517851&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:11:00</pubDate><description>NEW YORK (Reuters Health) - In premenopausal women with ER-positive breast cancer, high expression of serine-118-phosphorylated alpha estrogen receptors (ER-alpha-S118-P) is associated with an improved </description><source>Reuters Health</source></item><item><title>Roche seeks broader EU breast cancer label for drug</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96443006&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:09:00</pubDate><description>* EU approval sought for broader Avastin breast cancer use * Application based on study on benefits with chemotherapy ZURICH (Reuters) - Swiss drugmakerRoche Holding has filed for European approval to </description><source>Reuters Health</source></item><item><title>Implantable Cancer Vaccine Shows Promise</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96490282&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:06:00</pubDate><description>WEDNESDAY, Nov. 25 (HealthDay News) -- A cancer vaccine delivered in a fingernail-size implant eliminated melanoma tumors in mice, a new study reports. The method uses polymer disks, 8.5 millimeters in </description><source>KPTH Fox 44</source></item><item><title>Lonza to make trial stocks of Micromet cancer MAb</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96392204&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T02:42:00</pubDate><description>Related topics: Contract services (outsourcing) Lonza will produce trial supplies of Micrometā??s candidate blood cancer treatment blinatumomab under a contract announced today. The Swiss contractor will </description><source>In-Pharmatechnologist</source></item><item><title>Health advocacy group bands with Hadassah to fight new breast cancer screening guidelines</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96529177&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T03:18:00</pubDate><description>On the heels of an embarrassing flap that prevented two Israelis from attending a breast cancer conference in Egypt, Susan G. Komen for the Cure - which organized the event - announced a new partnership </description><source>Jerusalem Post</source></item><item><title>Clovis Oncology licenses cancer drug from Norwegian firm</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96371131&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T00:59:00</pubDate><description>Biotech startup Clovis Oncology Inc. has signed its first drug into its research pipeline, licensing an experimental pancreatic cancer treatment from a company in Norway. Boulder-based Clovis, formed </description><source>Biz Journals</source></item><item><title>Recent cancer screening changes leave many confused</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96323349&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:14:00</pubDate><description>Until better imaging and testing tools are developed, imperfect screening is going to lead to over-diagnosis and unnecessary treatment.  iStockphoto.com/Jeffrey Smith coreAdsCreate('wnsz_20', 'loc', '100', </description><source>KPTH Fox 44</source></item><item><title>Incyte and Novartis form licensing agreement for two haematology-oncology programmes</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96442077&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:55:00</pubDate><description>Drug discovery and development company Incyte Corp (NASDAQ:INCY) declared on Wednesday that it has signed a collaboration and licence agreement with Novartis for two of its investigational haematology-oncology </description><source>Individual.com</source></item><item><title>BackOffice Associates, LLC Announces Serving for a Cure To Benefit the Thomas Blake </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96500735&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T02:47:00</pubDate><description>The evening will feature American tennis stars James Blake and former World No. 1, Grand Slam champion Andy Roddick. BackOffice Partner and rising tennis star Melanie Oudin will be in attendance at a </description><source>Yahoo! Canada</source></item><item><title>Women should ignore new mammogram guideline, ex-NIH chief says</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96229513&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:13:00</pubDate><description>The new advice prompted an outcry from patient advocacy groups and professional societies that urge women to continue getting annual mammograms beginning at age 40. Ā© iStockphoto.com MONDAY, Nov. 23 </description><source>KPTH Fox 44</source></item><item><title>Mammogram Debate Highlights Major Reform Barrier</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96526480&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T02:46:00</pubDate><description>The debate over the USPSTF's mammogram recommendations show how far the American public has to go before it will accept any limits on healthcare.</description><source>BNET</source></item><item><title>Special Holiday For Cancer Patient | Ohio News Now</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96525951&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T02:41:00</pubDate><description>Or, log in with your Facebook account: Please add your comment: (plain text only please. Allowable HTML: &amp;lt;a&amp;gt;) 20 log in or sign up to start earning Butterfly Credits today! Track Comments: Notify </description><source>Care2</source></item><item><title>Study Reveals Cancer Patients' Views on Advanced Directives</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96524207&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T02:15:00</pubDate><description>Seriously ill cancer patients may harbor attitudes toward advanced directives -- particularly with     whom they wish to discuss them -- that appear paradoxical, according to research published online </description><source>Modern Medicine</source></item><item><title>Study Sheds Light on Chemo Effects in Lung Cancer</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96524205&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T02:15:00</pubDate><description>The effect of adjuvant cisplatin-based chemotherapy on survival in non-small-cell lung cancer may fade     over time, according to research published online Nov. 23 in the Journal of Clinical Oncology.</description><source>Modern Medicine</source></item><item><title>Device enables early skin tumor detection</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96408254&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T02:06:00</pubDate><description>Beer-Sheva, Israel -- Israeli medical scientists say they are developing a device that can detect skin tumors, including melanomas, before they are visible to the naked eye. Researchers at Ben-Gurion </description><source>The Money Times</source></item><item><title>TopAbstracts in Renal Cancer 11/25/2009</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96518350&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:18:00</pubDate><description>TopAbstractsā?¢ in Renal Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guideā?¢ newsletter or visited a website Powered by Doctor's Guideā?¢ </description><source>Doctors Guide</source></item><item><title>TopAbstracts in Prostate Cancer 11/25/2009</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96518285&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:17:00</pubDate><description>TopAbstractsā?¢ in Prostate Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guideā?¢ newsletter or visited a website Powered by Doctor's Guideā?¢ </description><source>Doctors Guide</source></item><item><title>Tree ornament sales to help fight cancer</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96408246&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:51:00</pubDate><description>A few local women who are cancer survivors or whose loved ones have been stricken with the disease are working this holiday season to help others like them. Loan Spear, Martha Littlefield-Settles and </description><source>Individual.com</source></item><item><title>Sky Foundation, Inc. Raises More Than $100,000 to Find a Test for Early Detection </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96352755&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:50:00</pubDate><description>Sky Foundation, Inc., a non-profit foundation dedicated to raising $500,000 to fund research to develop a blood test for the early detection of pancreatic cancer, today announced it has raised more that </description><source>Individual.com</source></item><item><title>Cancer: Skin implant that can destroy cancerous tumours</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96515043&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T00:36:00</pubDate><description>CANCER: SKIN IMPLANT THAT CAN DESTROY CANCEROUS TUMOURS Have your say(0) A TINY skin implant that can destroy cancerous tumours has been unveiled by scientists. The implant ā?? less than a centimetre </description><source>Daily Express</source></item><item><title>Tiny hidden disc 'can wipe out skin cancer'</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96514656&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T00:31:00</pubDate><description>By Last updated at 12:11 AM on 26th November 2009 Add to A disc the size of a fingernail that destroys the most dangerous form of skin cancer has been developed by scientists. Fitted under the skin, the </description><source>Mail Online UK</source></item><item><title>Indiana University Receives $10 Million for Breast Cancer Research</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96449074&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T00:07:00</pubDate><description>The in Fort Wayne, Indiana, has announced a $10 million commitment to the Melvin and Bren Simon Cancer Center at Indiana University for breast cancer research. The foundation, the philanthropic arm of </description><source>Philanthropy News Digest</source></item><item><title>Hutchinson Cancer Research Center Receives $10 Million Pledge for Immunotherapy </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96298516&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T00:07:00</pubDate><description>The Seattle-based has announced a $10 million pledge from Jeff and Jackie Bezos to help advance the field of immunotherapy research in order to treat and cure cancer. Established as a challenge to spur </description><source>Philanthropy News Digest</source></item><item><title>Crosstalk Between Critical Cell-Signaling Pathways Holds Clues To Tumor Invasion </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=96488259&amp;Channel_ID=22&amp;Category_ID=262</link><pubDate>2009-11-26T01:07:00</pubDate><description>Source:  University of Texas M. D. Anderson Cancer Center Newswise ā?? Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) </description><source>Newswise</source></item></channel></rss>